• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • English
    • Français
  • Canada
    • Répertoire du site Sandoz
Sandoz : A Novartis Division
  • Our Work
    • What We Do
    • Quality Generics
    • Biopharmaceuticals
    • Specialty Products
  • About Us
    • Who We Are
    • Corporate Responsibility
    • Doing Business Responsibly
    • Contact Us
    • Grants, Donations and Sponsorships
  • Products
    • Consumers
    • Patients
    • Healthcare Professionals
    • Patient Support Programs
  • News
    • Media Releases
    • Media Resource Center
    • Stay Up-To-Date
  • Careers
    • Available Positions
    • Diversity & Inclusion
    • Our Benefits
  • Sandoz-Connect Portal
Search
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
  • Jump to Comments
Stories/Global Impact

Novartis expands humanitarian efforts in Ukraine through donation of essential medicines

Mar 10, 2022

Novartis experts are working diligently to ensure continued supply of our medicines in Ukraine, where the health of patients who depend on these medicines is our priority.

We are expanding our humanitarian efforts in Ukraine by donating our inventory of essential medicines directly within the country, including much-needed antibiotics and painkillers from the Sandoz portfolio, for use in Ukrainian medical facilities. We are also working with the surrounding countries to supply medicines into Ukraine from outside of the country.

This is in addition to our initial donation of USD 3 million to three humanitarian organizations that help people in Ukraine and Ukrainian refugees in the neighboring countries.

    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Global Impact

Sandoz Canada Completes Sale of Sterile Injectable Medicine Manufacturing Plant

Global Impact

Sandoz Canada launches PrSandoz® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to PrTecfidera*

Global Impact

Sandoz Canada launches PrSandoz® Lenalidomide, a generic equivalent to PrRevlimid®

You are here

  1. Home ›
  2. Global Impact ›

Sandoz Canada

  • Notre travail
  • Our Work
  • À propos de nous
  • About Us
  • Produits
  • Products
  • Nouvelles
  • News
  • Carrières
  • Careers
  • Contactez-nous
  • Contact Us
  • Nous trouver
  • Office Locations
  • Rester à jour
  • Stay up to date

Subscribe to Sandoz

  • Facebook
  • Twitter
  • YouTube
  • LinkedIn
  • RSS
  • Sandoz Site Directory
© 2023 Sandoz AG

This site is intended for an audience in Canada

  • Termes d'utilisation
  • Terms of Use
  • Politique sur la vie privée
  • Privacy Policy
  • Terms of Trade
  • Return Policy
  • Politique d'achat
  • Politique de retour
  • Cookie Settings